 John Repine
Concepts (733)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neutrophils | 120 | 2005 | 1236 | 4.400 |
Why?
| | Interleukin-1 | 32 | 2015 | 964 | 2.880 |
Why?
| | Xanthine Oxidase | 43 | 2003 | 81 | 2.850 |
Why?
| | Lung | 93 | 2013 | 4052 | 2.610 |
Why?
| | Oxygen | 54 | 2016 | 930 | 2.590 |
Why?
| | Hydrogen Peroxide | 49 | 2002 | 327 | 2.160 |
Why?
| | Rats | 102 | 2015 | 5639 | 1.480 |
Why?
| | Catalase | 41 | 1997 | 130 | 1.340 |
Why?
| | Oxidative Stress | 12 | 2016 | 1314 | 1.330 |
Why?
| | Antioxidants | 13 | 2012 | 584 | 1.190 |
Why?
| | Superoxides | 28 | 1999 | 202 | 1.160 |
Why?
| | Pulmonary Edema | 23 | 1997 | 107 | 1.080 |
Why?
| | Thiourea | 29 | 1995 | 40 | 1.070 |
Why?
| | Macrophages, Alveolar | 4 | 2016 | 391 | 1.050 |
Why?
| | Rats, Sprague-Dawley | 38 | 2015 | 2486 | 1.010 |
Why?
| | Endothelium, Vascular | 16 | 2002 | 926 | 0.970 |
Why?
| | Bronchoalveolar Lavage Fluid | 15 | 2016 | 652 | 0.950 |
Why?
| | Ferritins | 5 | 2004 | 64 | 0.910 |
Why?
| | Animals | 173 | 2016 | 36823 | 0.900 |
Why?
| | Oxygen Inhalation Therapy | 2 | 2016 | 157 | 0.870 |
Why?
| | Xanthine Dehydrogenase | 14 | 1999 | 25 | 0.820 |
Why?
| | Ergothioneine | 2 | 2012 | 2 | 0.770 |
Why?
| | Lipopolysaccharides | 7 | 2015 | 886 | 0.720 |
Why?
| | Blood Bactericidal Activity | 21 | 1992 | 36 | 0.700 |
Why?
| | In Vitro Techniques | 46 | 2002 | 1089 | 0.680 |
Why?
| | Interferon Type I | 1 | 2021 | 140 | 0.670 |
Why?
| | Glutathione | 19 | 2000 | 356 | 0.650 |
Why?
| | Reperfusion Injury | 15 | 1997 | 279 | 0.640 |
Why?
| | Prostaglandins | 3 | 2019 | 97 | 0.640 |
Why?
| | Ischemia | 11 | 1997 | 407 | 0.630 |
Why?
| | Enzyme Inhibitors | 8 | 2004 | 839 | 0.630 |
Why?
| | Persian Gulf Syndrome | 1 | 2019 | 17 | 0.620 |
Why?
| | Chemokines, CXC | 6 | 2005 | 70 | 0.620 |
Why?
| | Leukotrienes | 1 | 2019 | 37 | 0.620 |
Why?
| | Free Radicals | 24 | 2008 | 110 | 0.610 |
Why?
| | Pneumonia | 6 | 2011 | 635 | 0.610 |
Why?
| | Pulmonary Alveoli | 23 | 2011 | 405 | 0.600 |
Why?
| | Capillary Permeability | 14 | 2002 | 145 | 0.600 |
Why?
| | Virus Diseases | 1 | 2021 | 211 | 0.600 |
Why?
| | Dimethyl Sulfoxide | 18 | 1994 | 41 | 0.590 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2021 | 213 | 0.590 |
Why?
| | Aerosols | 4 | 2016 | 176 | 0.590 |
Why?
| | Superoxide Dismutase | 27 | 1996 | 346 | 0.570 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2016 | 1036 | 0.560 |
Why?
| | Lung Injury | 9 | 2014 | 218 | 0.560 |
Why?
| | Rats, Inbred Strains | 37 | 1992 | 362 | 0.560 |
Why?
| | Chemotactic Factors | 11 | 1997 | 56 | 0.550 |
Why?
| | Receptors, Cell Surface | 2 | 2015 | 382 | 0.550 |
Why?
| | Intercellular Signaling Peptides and Proteins | 6 | 2005 | 382 | 0.550 |
Why?
| | Cytokines | 8 | 2014 | 2083 | 0.530 |
Why?
| | Oxidants | 6 | 2004 | 111 | 0.530 |
Why?
| | Respiratory Tract Infections | 1 | 2021 | 389 | 0.520 |
Why?
| | Chemotaxis, Leukocyte | 10 | 1997 | 136 | 0.510 |
Why?
| | Malathion | 1 | 2016 | 3 | 0.510 |
Why?
| | Staphylococcus aureus | 29 | 1988 | 449 | 0.500 |
Why?
| | Tetradecanoylphorbol Acetate | 20 | 1994 | 150 | 0.490 |
Why?
| | Leukocyte Elastase | 5 | 2002 | 76 | 0.480 |
Why?
| | Capillaries | 2 | 2015 | 108 | 0.480 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 61 | 0.470 |
Why?
| | Heme Oxygenase-1 | 1 | 2015 | 64 | 0.470 |
Why?
| | Platelet Activating Factor | 4 | 2002 | 76 | 0.470 |
Why?
| | Glutamine | 1 | 2015 | 103 | 0.460 |
Why?
| | Myocardial Reperfusion Injury | 9 | 1992 | 134 | 0.450 |
Why?
| | Macrophages | 24 | 1991 | 1544 | 0.450 |
Why?
| | Kidney | 11 | 1999 | 1467 | 0.450 |
Why?
| | Respiration, Artificial | 3 | 2015 | 642 | 0.440 |
Why?
| | Lung Diseases | 10 | 2007 | 767 | 0.430 |
Why?
| | Phagocytosis | 22 | 2007 | 379 | 0.430 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2015 | 313 | 0.420 |
Why?
| | Prostaglandin D2 | 1 | 2013 | 23 | 0.420 |
Why?
| | Quinacrine | 3 | 2004 | 9 | 0.420 |
Why?
| | Peroxidase | 15 | 2003 | 175 | 0.420 |
Why?
| | Hemorrhage | 4 | 2004 | 721 | 0.410 |
Why?
| | Neutrophil Infiltration | 1 | 2013 | 107 | 0.410 |
Why?
| | Perfusion | 22 | 2002 | 211 | 0.410 |
Why?
| | Hydroxides | 9 | 1991 | 26 | 0.410 |
Why?
| | Nitric Oxide | 8 | 2014 | 915 | 0.400 |
Why?
| | Male | 102 | 2019 | 67309 | 0.400 |
Why?
| | L-Lactate Dehydrogenase | 17 | 2013 | 121 | 0.390 |
Why?
| | Allopurinol | 11 | 2003 | 63 | 0.380 |
Why?
| | Antigens, CD | 1 | 2015 | 521 | 0.380 |
Why?
| | Myocardium | 14 | 1992 | 1001 | 0.380 |
Why?
| | Pulmonary Artery | 13 | 1997 | 1086 | 0.370 |
Why?
| | Serine Proteinase Inhibitors | 4 | 2002 | 47 | 0.370 |
Why?
| | Cell Adhesion | 15 | 2007 | 466 | 0.360 |
Why?
| | Inflammation | 6 | 2016 | 2834 | 0.360 |
Why?
| | Fruit | 1 | 2012 | 139 | 0.360 |
Why?
| | Aldehyde Oxidoreductases | 4 | 1999 | 27 | 0.350 |
Why?
| | Vegetables | 1 | 2012 | 156 | 0.350 |
Why?
| | Rabbits | 29 | 1991 | 792 | 0.350 |
Why?
| | Pancreatic Elastase | 8 | 1993 | 58 | 0.350 |
Why?
| | Tumor Necrosis Factor-alpha | 8 | 2005 | 1242 | 0.340 |
Why?
| | Cells, Cultured | 28 | 2008 | 4190 | 0.340 |
Why?
| | Tungsten | 15 | 2003 | 30 | 0.340 |
Why?
| | Pentoxifylline | 4 | 1997 | 25 | 0.340 |
Why?
| | Pulmonary Circulation | 6 | 2005 | 429 | 0.340 |
Why?
| | Burns | 4 | 2019 | 325 | 0.330 |
Why?
| | Reactive Oxygen Species | 5 | 1999 | 621 | 0.330 |
Why?
| | Cattle | 18 | 2007 | 981 | 0.320 |
Why?
| | Humans | 125 | 2021 | 136764 | 0.320 |
Why?
| | Heart | 10 | 1994 | 653 | 0.320 |
Why?
| | Erythrocytes | 11 | 1995 | 699 | 0.310 |
Why?
| | Oxidation-Reduction | 22 | 1999 | 1059 | 0.300 |
Why?
| | Deferoxamine | 3 | 2002 | 24 | 0.300 |
Why?
| | Tissue Plasminogen Activator | 3 | 2005 | 223 | 0.300 |
Why?
| | Phorbols | 8 | 1986 | 10 | 0.300 |
Why?
| | Soot | 1 | 2008 | 26 | 0.300 |
Why?
| | Vitamin E | 4 | 1998 | 124 | 0.300 |
Why?
| | Granulomatous Disease, Chronic | 12 | 1988 | 55 | 0.290 |
Why?
| | Biomarkers | 9 | 2019 | 4143 | 0.280 |
Why?
| | Gulf War | 2 | 2019 | 15 | 0.280 |
Why?
| | Oxygen Consumption | 19 | 1995 | 695 | 0.280 |
Why?
| | Receptors, Interleukin-1 | 4 | 1997 | 216 | 0.280 |
Why?
| | Dinoprost | 2 | 2019 | 44 | 0.280 |
Why?
| | Dietary Supplements | 1 | 2012 | 559 | 0.280 |
Why?
| | Tyrosine | 2 | 2008 | 222 | 0.270 |
Why?
| | Intercellular Adhesion Molecule-1 | 3 | 2007 | 139 | 0.260 |
Why?
| | Bacterial Infections | 7 | 1993 | 250 | 0.260 |
Why?
| | Phosphatidic Acids | 2 | 1997 | 9 | 0.260 |
Why?
| | Free Radical Scavengers | 8 | 2000 | 88 | 0.250 |
Why?
| | Trachea | 6 | 2005 | 237 | 0.250 |
Why?
| | Endothelium | 10 | 1997 | 122 | 0.250 |
Why?
| | Blood Platelets | 7 | 1992 | 405 | 0.250 |
Why?
| | Leukocytes | 7 | 2007 | 311 | 0.250 |
Why?
| | Shock, Septic | 3 | 2000 | 219 | 0.250 |
Why?
| | Particulate Matter | 1 | 2008 | 312 | 0.250 |
Why?
| | Phagocytes | 2 | 2003 | 100 | 0.240 |
Why?
| | Muscles | 3 | 1991 | 325 | 0.240 |
Why?
| | alpha-Tocopherol | 1 | 2005 | 33 | 0.230 |
Why?
| | Recombinant Proteins | 10 | 2005 | 1350 | 0.230 |
Why?
| | Administration, Inhalation | 5 | 2016 | 683 | 0.230 |
Why?
| | Leukotriene B4 | 3 | 2016 | 42 | 0.230 |
Why?
| | Krypton | 3 | 2011 | 4 | 0.230 |
Why?
| | Endotoxins | 7 | 1992 | 220 | 0.230 |
Why?
| | Obesity | 2 | 2015 | 2982 | 0.230 |
Why?
| | Tidal Volume | 2 | 2015 | 86 | 0.220 |
Why?
| | Coronary Disease | 5 | 1991 | 384 | 0.210 |
Why?
| | Growth Substances | 4 | 1997 | 147 | 0.210 |
Why?
| | Glutathione Peroxidase | 10 | 1994 | 43 | 0.210 |
Why?
| | Skin | 3 | 1995 | 751 | 0.210 |
Why?
| | Leukocyte Count | 8 | 2003 | 329 | 0.210 |
Why?
| | Mitochondria | 5 | 2008 | 946 | 0.210 |
Why?
| | Nitroblue Tetrazolium | 8 | 2000 | 12 | 0.210 |
Why?
| | Postoperative Complications | 1 | 2015 | 2639 | 0.200 |
Why?
| | Acute Kidney Injury | 3 | 1997 | 809 | 0.200 |
Why?
| | Intercellular Junctions | 1 | 2002 | 40 | 0.200 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2003 | 58 | 0.200 |
Why?
| | Cell Count | 4 | 2013 | 323 | 0.200 |
Why?
| | Iron Chelating Agents | 1 | 2002 | 18 | 0.200 |
Why?
| | Smoking | 7 | 2014 | 1620 | 0.190 |
Why?
| | Permeability | 7 | 2002 | 161 | 0.190 |
Why?
| | Iron | 8 | 2002 | 312 | 0.190 |
Why?
| | Organ Size | 10 | 1998 | 477 | 0.190 |
Why?
| | Amitrole | 8 | 1990 | 9 | 0.190 |
Why?
| | Environmental Exposure | 2 | 2017 | 572 | 0.190 |
Why?
| | Dose-Response Relationship, Drug | 7 | 2016 | 2052 | 0.190 |
Why?
| | Edema | 4 | 1997 | 129 | 0.190 |
Why?
| | Neutropenia | 5 | 1997 | 146 | 0.180 |
Why?
| | Particle Size | 3 | 2016 | 392 | 0.180 |
Why?
| | Thromboxanes | 4 | 1988 | 17 | 0.180 |
Why?
| | von Willebrand Factor | 3 | 2019 | 80 | 0.180 |
Why?
| | Corneal Stroma | 1 | 2001 | 17 | 0.180 |
Why?
| | Glycine | 1 | 2002 | 175 | 0.180 |
Why?
| | Administration, Intranasal | 1 | 2021 | 88 | 0.180 |
Why?
| | Photorefractive Keratectomy | 1 | 2001 | 19 | 0.180 |
Why?
| | Intubation, Intratracheal | 6 | 2002 | 257 | 0.170 |
Why?
| | Risk Factors | 9 | 2019 | 10326 | 0.170 |
Why?
| | Sodium | 2 | 1999 | 216 | 0.170 |
Why?
| | Air Pollutants, Occupational | 1 | 2001 | 40 | 0.170 |
Why?
| | Transforming Growth Factor beta | 1 | 2003 | 480 | 0.170 |
Why?
| | Renal Circulation | 4 | 1997 | 58 | 0.170 |
Why?
| | Chromosomes, Human, Pair 2 | 2 | 1997 | 29 | 0.170 |
Why?
| | Nitrates | 2 | 2017 | 92 | 0.160 |
Why?
| | Acute Disease | 8 | 1999 | 1004 | 0.160 |
Why?
| | Indicators and Reagents | 6 | 2000 | 106 | 0.160 |
Why?
| | Phagocyte Bactericidal Dysfunction | 5 | 1979 | 12 | 0.160 |
Why?
| | Kinetics | 12 | 1996 | 1663 | 0.160 |
Why?
| | Sialoglycoproteins | 2 | 1997 | 159 | 0.160 |
Why?
| | Chemokine CXCL1 | 4 | 2005 | 76 | 0.160 |
Why?
| | Saccharomyces cerevisiae | 3 | 1995 | 556 | 0.160 |
Why?
| | Alcohol Dehydrogenase | 1 | 1999 | 15 | 0.150 |
Why?
| | Lactoferrin | 2 | 2017 | 31 | 0.150 |
Why?
| | Triazoles | 3 | 2002 | 147 | 0.150 |
Why?
| | Physical Exertion | 1 | 2000 | 215 | 0.150 |
Why?
| | Luminescent Measurements | 8 | 1997 | 75 | 0.150 |
Why?
| | Female | 32 | 2019 | 72787 | 0.150 |
Why?
| | Interleukin-8 | 3 | 1997 | 268 | 0.150 |
Why?
| | Multiple Trauma | 1 | 1999 | 100 | 0.150 |
Why?
| | Monocytes | 7 | 2007 | 563 | 0.150 |
Why?
| | Brain Edema | 2 | 1990 | 61 | 0.150 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2000 | 220 | 0.140 |
Why?
| | Sulfonamides | 1 | 2002 | 513 | 0.140 |
Why?
| | Kidney Tubules, Proximal | 1 | 1999 | 127 | 0.140 |
Why?
| | Alprostadil | 2 | 1997 | 32 | 0.140 |
Why?
| | Acetylcysteine | 3 | 1995 | 145 | 0.140 |
Why?
| | Molybdenum | 1 | 1997 | 9 | 0.140 |
Why?
| | Veterans Health | 1 | 2019 | 185 | 0.140 |
Why?
| | Lung Diseases, Obstructive | 1 | 1997 | 50 | 0.140 |
Why?
| | Phospholipases A | 1 | 1997 | 102 | 0.130 |
Why?
| | Therapeutic Irrigation | 7 | 1997 | 77 | 0.130 |
Why?
| | Chronic Disease | 3 | 2014 | 1784 | 0.130 |
Why?
| | Neutrophil Activation | 1 | 1997 | 80 | 0.130 |
Why?
| | Polyethylene Glycols | 5 | 1990 | 640 | 0.130 |
Why?
| | Chromatography, Affinity | 1 | 1996 | 88 | 0.130 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2011 | 610 | 0.130 |
Why?
| | DNA Damage | 1 | 1999 | 420 | 0.120 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 1996 | 164 | 0.120 |
Why?
| | Sepsis | 2 | 2000 | 614 | 0.120 |
Why?
| | Fatty Acids, Unsaturated | 1 | 1996 | 98 | 0.120 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1996 | 159 | 0.120 |
Why?
| | Carbonates | 1 | 1995 | 10 | 0.120 |
Why?
| | Menstruation | 2 | 1986 | 43 | 0.120 |
Why?
| | One-Lung Ventilation | 1 | 2015 | 5 | 0.120 |
Why?
| | Adjuvants, Immunologic | 1 | 1997 | 226 | 0.120 |
Why?
| | Ethanol | 2 | 1999 | 606 | 0.120 |
Why?
| | Pulmonary Surfactants | 3 | 2007 | 106 | 0.120 |
Why?
| | Hypoxia | 3 | 2015 | 1112 | 0.120 |
Why?
| | Mice, Inbred Strains | 1 | 2016 | 409 | 0.120 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 851 | 0.120 |
Why?
| | Vitamin E Deficiency | 1 | 1995 | 43 | 0.120 |
Why?
| | Sodium Bicarbonate | 1 | 1995 | 45 | 0.120 |
Why?
| | Predictive Value of Tests | 5 | 2019 | 2022 | 0.120 |
Why?
| | Vinblastine | 6 | 1997 | 70 | 0.120 |
Why?
| | Interleukin-10 | 1 | 1997 | 302 | 0.120 |
Why?
| | Serum Albumin | 4 | 1994 | 150 | 0.120 |
Why?
| | Muscle, Smooth, Vascular | 2 | 1997 | 445 | 0.110 |
Why?
| | Glutathione Disulfide | 5 | 1994 | 33 | 0.110 |
Why?
| | Positive-Pressure Respiration | 1 | 2015 | 80 | 0.110 |
Why?
| | Oligonucleotides | 1 | 1995 | 148 | 0.110 |
Why?
| | Critical Care | 1 | 2000 | 583 | 0.110 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 1994 | 43 | 0.110 |
Why?
| | Vasoconstriction | 3 | 1988 | 202 | 0.110 |
Why?
| | Reperfusion | 2 | 1992 | 40 | 0.110 |
Why?
| | Cell Movement | 6 | 1996 | 965 | 0.110 |
Why?
| | Carbon Dioxide | 2 | 1995 | 267 | 0.110 |
Why?
| | Case-Control Studies | 2 | 2019 | 3540 | 0.110 |
Why?
| | Insufflation | 1 | 2013 | 12 | 0.110 |
Why?
| | Granulocytes | 3 | 1982 | 80 | 0.110 |
Why?
| | Liposomes | 3 | 1997 | 220 | 0.110 |
Why?
| | Liver | 2 | 2000 | 1940 | 0.100 |
Why?
| | Hemolysis | 2 | 1993 | 206 | 0.100 |
Why?
| | Oligopeptides | 2 | 1992 | 271 | 0.100 |
Why?
| | Smoke | 2 | 2007 | 140 | 0.100 |
Why?
| | Perioperative Care | 1 | 2015 | 178 | 0.100 |
Why?
| | Molecular Sequence Data | 6 | 1999 | 2892 | 0.100 |
Why?
| | Purines | 4 | 2002 | 176 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2822 | 0.100 |
Why?
| | Hydroxyl Radical | 7 | 1991 | 92 | 0.100 |
Why?
| | Hypertension, Pulmonary | 5 | 1987 | 1905 | 0.100 |
Why?
| | Pleural Effusion | 4 | 1992 | 54 | 0.100 |
Why?
| | Serpins | 1 | 1992 | 31 | 0.100 |
Why?
| | Sulfhydryl Compounds | 3 | 1992 | 189 | 0.100 |
Why?
| | Microscopy, Electron | 6 | 2000 | 432 | 0.100 |
Why?
| | Glucose Oxidase | 3 | 1987 | 26 | 0.100 |
Why?
| | Tetrazolium Salts | 5 | 1991 | 17 | 0.100 |
Why?
| | Opsonin Proteins | 7 | 1988 | 25 | 0.090 |
Why?
| | Acute Lung Injury | 1 | 2015 | 287 | 0.090 |
Why?
| | Disease Susceptibility | 1 | 2014 | 345 | 0.090 |
Why?
| | Escherichia coli | 4 | 1988 | 806 | 0.090 |
Why?
| | Respiration | 3 | 2001 | 199 | 0.090 |
Why?
| | Complement C2 | 4 | 1979 | 7 | 0.090 |
Why?
| | Inhalation | 1 | 2011 | 29 | 0.090 |
Why?
| | Cell Hypoxia | 1 | 1992 | 226 | 0.090 |
Why?
| | Melanocytes | 1 | 1991 | 65 | 0.090 |
Why?
| | Azepines | 2 | 2002 | 90 | 0.090 |
Why?
| | Brain | 3 | 1992 | 2664 | 0.090 |
Why?
| | Oxidoreductases | 1 | 1991 | 92 | 0.090 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 3 | 1997 | 54 | 0.090 |
Why?
| | Muramidase | 3 | 1988 | 77 | 0.090 |
Why?
| | Leukocytes, Mononuclear | 2 | 1991 | 558 | 0.090 |
Why?
| | Salmonella typhimurium | 2 | 1991 | 183 | 0.090 |
Why?
| | Electron Spin Resonance Spectroscopy | 2 | 2008 | 95 | 0.090 |
Why?
| | Phosphorylation | 1 | 2015 | 1758 | 0.090 |
Why?
| | Xenon Isotopes | 2 | 2007 | 6 | 0.090 |
Why?
| | Adult | 22 | 2019 | 37630 | 0.080 |
Why?
| | Shock | 1 | 1991 | 95 | 0.080 |
Why?
| | Middle Aged | 10 | 2019 | 33228 | 0.080 |
Why?
| | Diterpenes | 3 | 1975 | 31 | 0.080 |
Why?
| | Base Sequence | 5 | 1999 | 2179 | 0.080 |
Why?
| | Riboflavin | 1 | 1990 | 7 | 0.080 |
Why?
| | Paraquat | 1 | 1990 | 14 | 0.080 |
Why?
| | Glycoconjugates | 1 | 1990 | 7 | 0.080 |
Why?
| | Keratinocytes | 1 | 1991 | 248 | 0.080 |
Why?
| | Diabetes Mellitus | 2 | 2014 | 1032 | 0.080 |
Why?
| | Fibroblasts | 3 | 1991 | 993 | 0.080 |
Why?
| | Blood Cells | 1 | 1990 | 40 | 0.080 |
Why?
| | Arachidonic Acids | 1 | 1990 | 62 | 0.080 |
Why?
| | Factor VII | 1 | 1989 | 24 | 0.080 |
Why?
| | Hyperbaric Oxygenation | 2 | 1987 | 39 | 0.080 |
Why?
| | Aldehyde Oxidase | 3 | 1999 | 3 | 0.080 |
Why?
| | Substrate Specificity | 3 | 1996 | 371 | 0.080 |
Why?
| | Reference Values | 4 | 1997 | 816 | 0.080 |
Why?
| | Intestines | 1 | 1992 | 357 | 0.080 |
Why?
| | Alkaline Phosphatase | 3 | 1986 | 148 | 0.080 |
Why?
| | Mycobacterium bovis | 3 | 1985 | 16 | 0.080 |
Why?
| | Metals | 1 | 1990 | 136 | 0.080 |
Why?
| | Krypton Radioisotopes | 1 | 2008 | 1 | 0.080 |
Why?
| | Biological Factors | 1 | 1989 | 39 | 0.080 |
Why?
| | RNA | 1 | 1995 | 921 | 0.080 |
Why?
| | Myocardial Reperfusion | 4 | 1994 | 50 | 0.070 |
Why?
| | Superantigens | 1 | 1988 | 70 | 0.070 |
Why?
| | Enterotoxins | 1 | 1988 | 87 | 0.070 |
Why?
| | Time Factors | 10 | 2000 | 6806 | 0.070 |
Why?
| | Exercise | 1 | 2000 | 2043 | 0.070 |
Why?
| | RNA, Messenger | 4 | 2005 | 2831 | 0.070 |
Why?
| | Antigens | 2 | 1989 | 357 | 0.070 |
Why?
| | Thromboxane B2 | 2 | 1988 | 26 | 0.070 |
Why?
| | Nitroarginine | 2 | 1999 | 56 | 0.070 |
Why?
| | Mice | 5 | 2016 | 17733 | 0.070 |
Why?
| | Amino Acid Sequence | 3 | 1999 | 2136 | 0.070 |
Why?
| | Nitroprusside | 2 | 1999 | 69 | 0.070 |
Why?
| | Bacterial Toxins | 1 | 1988 | 105 | 0.070 |
Why?
| | Blood Pressure | 6 | 1995 | 1774 | 0.070 |
Why?
| | Proteins | 5 | 1997 | 1008 | 0.070 |
Why?
| | Integrin alpha4beta1 | 1 | 2007 | 8 | 0.070 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 1 | 2007 | 30 | 0.070 |
Why?
| | Inhalation Exposure | 1 | 2008 | 105 | 0.070 |
Why?
| | Bronchoalveolar Lavage | 2 | 1998 | 93 | 0.070 |
Why?
| | Epithelial Cells | 2 | 2007 | 1094 | 0.070 |
Why?
| | Nylons | 3 | 1984 | 18 | 0.070 |
Why?
| | Glomerular Filtration Rate | 4 | 1997 | 745 | 0.070 |
Why?
| | Creatine Kinase | 3 | 2000 | 79 | 0.070 |
Why?
| | Image Enhancement | 1 | 2008 | 190 | 0.070 |
Why?
| | Phospholipids | 2 | 2000 | 222 | 0.070 |
Why?
| | Zymosan | 5 | 1990 | 65 | 0.070 |
Why?
| | Alcoholism | 1 | 2014 | 804 | 0.070 |
Why?
| | Glucosephosphate Dehydrogenase | 3 | 1994 | 60 | 0.070 |
Why?
| | Disease | 2 | 2017 | 98 | 0.070 |
Why?
| | Thromboxane A2 | 2 | 1983 | 11 | 0.060 |
Why?
| | Cell Separation | 2 | 1997 | 317 | 0.060 |
Why?
| | Complement Activation | 3 | 1995 | 410 | 0.060 |
Why?
| | Ischemic Attack, Transient | 1 | 1987 | 65 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 1999 | 2234 | 0.060 |
Why?
| | DNA, Complementary | 2 | 1999 | 271 | 0.060 |
Why?
| | Cell Division | 2 | 1985 | 792 | 0.060 |
Why?
| | Arginine | 2 | 1998 | 271 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 2 | 1999 | 385 | 0.060 |
Why?
| | Cytochrome c Group | 3 | 1994 | 43 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 2 | 2008 | 3555 | 0.060 |
Why?
| | Menstrual Cycle | 1 | 1986 | 133 | 0.060 |
Why?
| | NF-kappa B | 2 | 2002 | 691 | 0.060 |
Why?
| | Polymerase Chain Reaction | 3 | 1999 | 1059 | 0.060 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 1985 | 52 | 0.060 |
Why?
| | Cloning, Molecular | 2 | 1999 | 534 | 0.060 |
Why?
| | Contrast Media | 1 | 2008 | 462 | 0.060 |
Why?
| | HEPES | 1 | 1985 | 2 | 0.060 |
Why?
| | Glycoproteins | 1 | 1987 | 342 | 0.060 |
Why?
| | Cerebrovascular Circulation | 1 | 1987 | 241 | 0.060 |
Why?
| | Agranulocytosis | 2 | 1982 | 30 | 0.060 |
Why?
| | Drug Carriers | 2 | 1997 | 127 | 0.060 |
Why?
| | Isotopes | 3 | 2011 | 33 | 0.060 |
Why?
| | Staphylococcal Infections | 2 | 1986 | 399 | 0.060 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 2 | 1997 | 253 | 0.060 |
Why?
| | Models, Biological | 4 | 2011 | 1773 | 0.060 |
Why?
| | Peroxidases | 2 | 1991 | 34 | 0.060 |
Why?
| | Spectrophotometry, Ultraviolet | 2 | 2017 | 86 | 0.060 |
Why?
| | Mesocricetus | 2 | 1995 | 39 | 0.050 |
Why?
| | Mannitol | 4 | 1991 | 38 | 0.050 |
Why?
| | Enzyme Induction | 1 | 2003 | 90 | 0.050 |
Why?
| | Tuberculoma | 1 | 1983 | 2 | 0.050 |
Why?
| | Genetic Therapy | 1 | 2005 | 293 | 0.050 |
Why?
| | Lidocaine | 3 | 1987 | 42 | 0.050 |
Why?
| | Iron, Dietary | 1 | 2003 | 22 | 0.050 |
Why?
| | Aspirin | 2 | 1984 | 387 | 0.050 |
Why?
| | Cricetinae | 2 | 1995 | 289 | 0.050 |
Why?
| | Kidney Diseases | 1 | 1987 | 407 | 0.050 |
Why?
| | Vasodilator Agents | 2 | 1999 | 331 | 0.050 |
Why?
| | Osmolar Concentration | 3 | 1994 | 171 | 0.050 |
Why?
| | Methylprednisolone | 1 | 1983 | 85 | 0.050 |
Why?
| | Thiobarbituric Acid Reactive Substances | 1 | 2002 | 30 | 0.050 |
Why?
| | Tetracaine | 2 | 1979 | 4 | 0.050 |
Why?
| | Carrier Proteins | 2 | 1997 | 769 | 0.050 |
Why?
| | Piperazines | 1 | 1985 | 350 | 0.050 |
Why?
| | Hematocrit | 3 | 1992 | 96 | 0.050 |
Why?
| | Blastomycosis | 2 | 1981 | 10 | 0.050 |
Why?
| | Cryptococcus | 1 | 1982 | 11 | 0.050 |
Why?
| | Leukemia, Myeloid | 2 | 1979 | 45 | 0.050 |
Why?
| | Cryptococcus neoformans | 1 | 1982 | 21 | 0.050 |
Why?
| | Chediak-Higashi Syndrome | 2 | 1979 | 7 | 0.050 |
Why?
| | Pyelonephritis | 1 | 1982 | 10 | 0.050 |
Why?
| | Drug Delivery Systems | 1 | 2005 | 362 | 0.050 |
Why?
| | Xanthogranuloma, Juvenile | 1 | 1982 | 6 | 0.050 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1983 | 141 | 0.050 |
Why?
| | Chromatography, Gas | 3 | 1988 | 33 | 0.050 |
Why?
| | Nitrogen Mustard Compounds | 1 | 1981 | 8 | 0.050 |
Why?
| | Disease Models, Animal | 3 | 1998 | 4281 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 3 | 1995 | 560 | 0.050 |
Why?
| | Environmental Pollution | 1 | 2001 | 20 | 0.040 |
Why?
| | Signal Transduction | 1 | 1995 | 5075 | 0.040 |
Why?
| | Volatilization | 1 | 2001 | 56 | 0.040 |
Why?
| | DNA, Superhelical | 1 | 1981 | 11 | 0.040 |
Why?
| | Complement Pathway, Alternative | 1 | 1982 | 122 | 0.040 |
Why?
| | Lasers, Excimer | 1 | 2001 | 28 | 0.040 |
Why?
| | 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 2 | 1992 | 6 | 0.040 |
Why?
| | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 2 | 1992 | 10 | 0.040 |
Why?
| | Microscopy, Electron, Scanning | 4 | 1990 | 200 | 0.040 |
Why?
| | Mycoses | 1 | 1981 | 79 | 0.040 |
Why?
| | Urea | 3 | 1990 | 81 | 0.040 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2000 | 36 | 0.040 |
Why?
| | Prospective Studies | 3 | 2019 | 7572 | 0.040 |
Why?
| | Malondialdehyde | 1 | 2000 | 29 | 0.040 |
Why?
| | Glucose | 8 | 1980 | 1019 | 0.040 |
Why?
| | DNA Primers | 2 | 1999 | 514 | 0.040 |
Why?
| | Organ Preservation | 2 | 1991 | 102 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 1997 | 1935 | 0.040 |
Why?
| | Ethylenes | 1 | 1979 | 9 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2003 | 788 | 0.040 |
Why?
| | Aspartate Aminotransferases | 1 | 2000 | 90 | 0.040 |
Why?
| | Methylurea Compounds | 2 | 1994 | 7 | 0.040 |
Why?
| | 6-Aminonicotinamide | 2 | 1990 | 2 | 0.040 |
Why?
| | Glutathione Reductase | 2 | 1990 | 25 | 0.040 |
Why?
| | Chemical Phenomena | 2 | 1995 | 83 | 0.040 |
Why?
| | DNA, Single-Stranded | 1 | 1981 | 118 | 0.040 |
Why?
| | Coronary Circulation | 3 | 1991 | 140 | 0.040 |
Why?
| | Biological Transport | 2 | 1999 | 416 | 0.040 |
Why?
| | Premedication | 3 | 1985 | 44 | 0.040 |
Why?
| | Chemotaxis | 2 | 1979 | 130 | 0.040 |
Why?
| | Bradykinin | 1 | 1999 | 46 | 0.040 |
Why?
| | Hot Temperature | 3 | 1994 | 391 | 0.040 |
Why?
| | Radioimmunoassay | 2 | 1997 | 173 | 0.040 |
Why?
| | Cyclic GMP | 1 | 1999 | 93 | 0.040 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 1999 | 49 | 0.040 |
Why?
| | Chromosome Mapping | 2 | 1997 | 523 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2000 | 455 | 0.040 |
Why?
| | Albumins | 3 | 1991 | 113 | 0.040 |
Why?
| | Hyperoxia | 1 | 1999 | 90 | 0.040 |
Why?
| | DNA, Viral | 1 | 1981 | 363 | 0.040 |
Why?
| | Instillation, Drug | 1 | 1998 | 10 | 0.040 |
Why?
| | Anesthetics, Local | 1 | 1979 | 80 | 0.040 |
Why?
| | Myocardial Contraction | 3 | 1989 | 339 | 0.040 |
Why?
| | Gerbillinae | 2 | 1990 | 65 | 0.040 |
Why?
| | Culture Techniques | 2 | 1992 | 81 | 0.040 |
Why?
| | Myocardial Infarction | 3 | 1991 | 1041 | 0.040 |
Why?
| | Acetylcholine | 1 | 1999 | 185 | 0.040 |
Why?
| | Injections, Intraperitoneal | 1 | 1998 | 114 | 0.040 |
Why?
| | Coculture Techniques | 1 | 1999 | 239 | 0.040 |
Why?
| | Pulmonary Ventilation | 2 | 2011 | 79 | 0.040 |
Why?
| | Levamisole | 1 | 1977 | 19 | 0.040 |
Why?
| | Cloning, Organism | 1 | 1997 | 6 | 0.030 |
Why?
| | Oleic Acid | 1 | 1997 | 40 | 0.030 |
Why?
| | Linoleic Acid | 1 | 1997 | 43 | 0.030 |
Why?
| | Phospholipases A2 | 1 | 1997 | 80 | 0.030 |
Why?
| | Muscle Contraction | 2 | 1990 | 423 | 0.030 |
Why?
| | Spectrometry, Fluorescence | 1 | 2017 | 168 | 0.030 |
Why?
| | Electron Transport | 2 | 1995 | 115 | 0.030 |
Why?
| | Methane | 3 | 1983 | 49 | 0.030 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 1997 | 25 | 0.030 |
Why?
| | NADP | 2 | 1988 | 49 | 0.030 |
Why?
| | Absorption | 1 | 1997 | 63 | 0.030 |
Why?
| | Injury Severity Score | 1 | 1999 | 521 | 0.030 |
Why?
| | HIV Infections | 1 | 1992 | 2828 | 0.030 |
Why?
| | Tumor Necrosis Factor Decoy Receptors | 1 | 1996 | 8 | 0.030 |
Why?
| | Complement System Proteins | 2 | 1977 | 327 | 0.030 |
Why?
| | Benzamidines | 1 | 1996 | 3 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2001 | 539 | 0.030 |
Why?
| | Isoelectric Point | 1 | 1996 | 25 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 1990 | 597 | 0.030 |
Why?
| | Hydrolysis | 1 | 1997 | 176 | 0.030 |
Why?
| | Xanthines | 1 | 1996 | 19 | 0.030 |
Why?
| | Sepharose | 1 | 1996 | 34 | 0.030 |
Why?
| | Immunoassay | 1 | 1997 | 113 | 0.030 |
Why?
| | Blood Proteins | 1 | 1978 | 252 | 0.030 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 1996 | 87 | 0.030 |
Why?
| | Sodium Chloride | 2 | 1990 | 142 | 0.030 |
Why?
| | Endocarditis, Bacterial | 1 | 1976 | 41 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1430 | 0.030 |
Why?
| | Interleukin-4 | 1 | 1997 | 216 | 0.030 |
Why?
| | Aged | 5 | 2019 | 23794 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 1998 | 785 | 0.030 |
Why?
| | Adenine | 2 | 1997 | 270 | 0.030 |
Why?
| | Chemistry, Physical | 1 | 1995 | 37 | 0.030 |
Why?
| | Cathepsin G | 1 | 1995 | 6 | 0.030 |
Why?
| | Cathepsins | 1 | 1995 | 24 | 0.030 |
Why?
| | Injections | 1 | 1996 | 183 | 0.030 |
Why?
| | Diet | 4 | 1995 | 1274 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2003 | 1982 | 0.030 |
Why?
| | Hydrochloric Acid | 1 | 1995 | 9 | 0.030 |
Why?
| | Sex Chromosomes | 1 | 1975 | 50 | 0.030 |
Why?
| | Single-Blind Method | 1 | 1996 | 282 | 0.030 |
Why?
| | Cross Reactions | 1 | 1995 | 133 | 0.030 |
Why?
| | Isoenzymes | 1 | 1996 | 304 | 0.030 |
Why?
| | Injections, Spinal | 1 | 1995 | 105 | 0.030 |
Why?
| | Erythrocyte Indices | 1 | 1995 | 30 | 0.030 |
Why?
| | ROC Curve | 1 | 1997 | 545 | 0.030 |
Why?
| | Factor VIII | 2 | 1993 | 98 | 0.030 |
Why?
| | Serine Endopeptidases | 1 | 1995 | 123 | 0.030 |
Why?
| | Uteroglobin | 1 | 2014 | 23 | 0.030 |
Why?
| | Acyltransferases | 1 | 1995 | 56 | 0.030 |
Why?
| | Tuberculosis, Pleural | 2 | 1985 | 6 | 0.030 |
Why?
| | Cytosol | 1 | 1995 | 226 | 0.030 |
Why?
| | Croton Oil | 1 | 1974 | 3 | 0.030 |
Why?
| | Adolescent | 8 | 1999 | 21382 | 0.030 |
Why?
| | Hydroxyurea | 1 | 1994 | 35 | 0.030 |
Why?
| | Lipoxygenase Inhibitors | 1 | 1994 | 37 | 0.030 |
Why?
| | Leukotriene Antagonists | 1 | 1994 | 43 | 0.030 |
Why?
| | Ficoll | 1 | 1994 | 5 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 1997 | 408 | 0.030 |
Why?
| | Nitrites | 1 | 2014 | 84 | 0.030 |
Why?
| | Drug Tolerance | 1 | 1994 | 105 | 0.030 |
Why?
| | Apoptosis | 1 | 2003 | 2551 | 0.030 |
Why?
| | United States | 1 | 2011 | 14691 | 0.030 |
Why?
| | Enzyme Activation | 3 | 1991 | 810 | 0.030 |
Why?
| | Anions | 3 | 1995 | 31 | 0.030 |
Why?
| | Serum Albumin, Radio-Iodinated | 1 | 1994 | 6 | 0.030 |
Why?
| | Methods | 2 | 1984 | 65 | 0.030 |
Why?
| | Drug Combinations | 1 | 1995 | 343 | 0.030 |
Why?
| | Breath Tests | 1 | 1994 | 87 | 0.030 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 1995 | 88 | 0.030 |
Why?
| | Restriction Mapping | 1 | 1993 | 77 | 0.030 |
Why?
| | Dogs | 6 | 1991 | 411 | 0.030 |
Why?
| | Pressure | 2 | 1986 | 221 | 0.030 |
Why?
| | Diptera | 1 | 1993 | 30 | 0.030 |
Why?
| | Stomach | 1 | 1994 | 110 | 0.030 |
Why?
| | Genes | 1 | 1993 | 230 | 0.030 |
Why?
| | Clinical Enzyme Tests | 1 | 1993 | 11 | 0.030 |
Why?
| | Haploidy | 1 | 1993 | 25 | 0.030 |
Why?
| | Myocardial Ischemia | 1 | 1994 | 262 | 0.030 |
Why?
| | Sequence Alignment | 1 | 1993 | 342 | 0.030 |
Why?
| | Shock, Hemorrhagic | 1 | 1995 | 167 | 0.030 |
Why?
| | Epoprostenol | 2 | 1991 | 136 | 0.020 |
Why?
| | Platelet Count | 2 | 1984 | 85 | 0.020 |
Why?
| | Hemoglobins | 1 | 1995 | 353 | 0.020 |
Why?
| | Drosophila | 1 | 1993 | 151 | 0.020 |
Why?
| | Chromium | 1 | 1992 | 15 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 1992 | 206 | 0.020 |
Why?
| | Biomechanical Phenomena | 2 | 1987 | 806 | 0.020 |
Why?
| | Survival Rate | 1 | 1997 | 1962 | 0.020 |
Why?
| | Gene Expression | 2 | 1995 | 1500 | 0.020 |
Why?
| | Glucosephosphates | 1 | 1991 | 3 | 0.020 |
Why?
| | Glucose-6-Phosphate | 1 | 1991 | 6 | 0.020 |
Why?
| | Elapid Venoms | 1 | 1991 | 18 | 0.020 |
Why?
| | Membrane Proteins | 1 | 1978 | 1163 | 0.020 |
Why?
| | Mechlorethamine | 2 | 1982 | 60 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3264 | 0.020 |
Why?
| | Double-Blind Method | 1 | 1996 | 1981 | 0.020 |
Why?
| | Ethylmaleimide | 2 | 1989 | 18 | 0.020 |
Why?
| | Disease Progression | 1 | 1999 | 2750 | 0.020 |
Why?
| | Pentetic Acid | 1 | 1991 | 13 | 0.020 |
Why?
| | Indoles | 1 | 1994 | 410 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 1995 | 887 | 0.020 |
Why?
| | Sodium Azide | 1 | 1990 | 5 | 0.020 |
Why?
| | Ventricular Function | 1 | 1991 | 61 | 0.020 |
Why?
| | Formaldehyde | 1 | 1991 | 63 | 0.020 |
Why?
| | Azides | 1 | 1990 | 46 | 0.020 |
Why?
| | Alcohols | 3 | 1975 | 27 | 0.020 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1992 | 230 | 0.020 |
Why?
| | Edetic Acid | 1 | 1990 | 50 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2000 | 1710 | 0.020 |
Why?
| | Arteries | 2 | 1988 | 269 | 0.020 |
Why?
| | Guinea Pigs | 1 | 1990 | 158 | 0.020 |
Why?
| | Brain Chemistry | 1 | 1990 | 116 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 1990 | 156 | 0.020 |
Why?
| | Enzyme Stability | 2 | 2005 | 70 | 0.020 |
Why?
| | Body Weight | 1 | 1994 | 985 | 0.020 |
Why?
| | Methionine | 1 | 1990 | 160 | 0.020 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2014 | 359 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 1996 | 755 | 0.020 |
Why?
| | Catalysis | 1 | 1990 | 307 | 0.020 |
Why?
| | Heart Arrest, Induced | 1 | 1989 | 31 | 0.020 |
Why?
| | Analysis of Variance | 1 | 1992 | 1316 | 0.020 |
Why?
| | Cell Survival | 2 | 1990 | 1114 | 0.020 |
Why?
| | Carmustine | 1 | 1988 | 50 | 0.020 |
Why?
| | Streptococcus pneumoniae | 2 | 1981 | 169 | 0.020 |
Why?
| | Epithelium | 1 | 1990 | 311 | 0.020 |
Why?
| | Pentose Phosphate Pathway | 1 | 1988 | 53 | 0.020 |
Why?
| | Biological Assay | 2 | 1981 | 123 | 0.020 |
Why?
| | Campylobacter fetus | 1 | 1988 | 1 | 0.020 |
Why?
| | Protamines | 1 | 1988 | 7 | 0.020 |
Why?
| | Prognosis | 1 | 1997 | 4013 | 0.020 |
Why?
| | Campylobacter Infections | 1 | 1988 | 17 | 0.020 |
Why?
| | Temperature | 2 | 1983 | 675 | 0.020 |
Why?
| | Papaverine | 1 | 1987 | 2 | 0.020 |
Why?
| | Microbial Collagenase | 1 | 1987 | 12 | 0.020 |
Why?
| | Interleukin-2 | 1 | 1989 | 455 | 0.020 |
Why?
| | Helium | 1 | 2007 | 6 | 0.020 |
Why?
| | Antimycin A | 2 | 1995 | 14 | 0.020 |
Why?
| | Organ Specificity | 1 | 1988 | 304 | 0.020 |
Why?
| | Tissue Fixation | 1 | 2007 | 36 | 0.020 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 39 | 0.020 |
Why?
| | Constriction | 1 | 1987 | 47 | 0.020 |
Why?
| | Hemiplegia | 1 | 1987 | 21 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 1986 | 5106 | 0.020 |
Why?
| | Nicotine | 1 | 1990 | 334 | 0.020 |
Why?
| | Membranes | 1 | 1987 | 19 | 0.020 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1987 | 114 | 0.020 |
Why?
| | Heart Ventricles | 2 | 1989 | 785 | 0.020 |
Why?
| | Fatty Acids | 3 | 1975 | 442 | 0.020 |
Why?
| | Complement C3 | 1 | 1988 | 209 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 345 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 1988 | 473 | 0.020 |
Why?
| | Phantoms, Imaging | 1 | 2007 | 151 | 0.020 |
Why?
| | Cell Membrane | 3 | 1978 | 735 | 0.020 |
Why?
| | Brain Ischemia | 1 | 1990 | 338 | 0.020 |
Why?
| | Carboxypeptidases | 1 | 1985 | 13 | 0.020 |
Why?
| | Drug Synergism | 1 | 1986 | 382 | 0.020 |
Why?
| | Tissue Adhesions | 1 | 1985 | 32 | 0.020 |
Why?
| | Surface Properties | 1 | 2007 | 412 | 0.020 |
Why?
| | Carotid Arteries | 1 | 1987 | 206 | 0.020 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2005 | 105 | 0.010 |
Why?
| | Sneezing | 1 | 1985 | 1 | 0.010 |
Why?
| | Lipid Peroxides | 1 | 1985 | 10 | 0.010 |
Why?
| | Granuloma | 1 | 1985 | 91 | 0.010 |
Why?
| | Respiratory Physiological Phenomena | 1 | 1985 | 31 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1987 | 487 | 0.010 |
Why?
| | Cell Communication | 1 | 1987 | 315 | 0.010 |
Why?
| | Sheep | 2 | 1988 | 856 | 0.010 |
Why?
| | Blotting, Western | 1 | 2007 | 1225 | 0.010 |
Why?
| | Rheology | 1 | 1985 | 92 | 0.010 |
Why?
| | Hemodynamics | 4 | 1991 | 1110 | 0.010 |
Why?
| | Mucous Membrane | 1 | 1985 | 125 | 0.010 |
Why?
| | Pleurisy | 1 | 1983 | 5 | 0.010 |
Why?
| | Cyanamide | 1 | 1983 | 1 | 0.010 |
Why?
| | Singlet Oxygen | 1 | 1984 | 18 | 0.010 |
Why?
| | Cough | 1 | 1985 | 122 | 0.010 |
Why?
| | Blood Glucose | 4 | 1983 | 2181 | 0.010 |
Why?
| | Radiation Injuries, Experimental | 1 | 1983 | 22 | 0.010 |
Why?
| | Behavior, Animal | 1 | 1987 | 497 | 0.010 |
Why?
| | Respiratory System | 1 | 1985 | 157 | 0.010 |
Why?
| | Dietary Proteins | 1 | 1985 | 135 | 0.010 |
Why?
| | Molecular Weight | 1 | 1983 | 335 | 0.010 |
Why?
| | Prostanoic Acids | 1 | 1983 | 1 | 0.010 |
Why?
| | BCG Vaccine | 1 | 1983 | 24 | 0.010 |
Why?
| | Bacteria | 2 | 1981 | 854 | 0.010 |
Why?
| | Immunization | 1 | 1985 | 411 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1733 | 0.010 |
Why?
| | Immunity, Cellular | 1 | 1985 | 268 | 0.010 |
Why?
| | Mammals | 1 | 1985 | 283 | 0.010 |
Why?
| | Mycobacterium tuberculosis | 1 | 1986 | 310 | 0.010 |
Why?
| | Fibrinolytic Agents | 1 | 2005 | 270 | 0.010 |
Why?
| | Dietary Fats | 1 | 1985 | 304 | 0.010 |
Why?
| | Macrophage Activation | 1 | 1984 | 201 | 0.010 |
Why?
| | Mice, Inbred BALB C | 2 | 1996 | 1269 | 0.010 |
Why?
| | Blood Physiological Phenomena | 1 | 1982 | 13 | 0.010 |
Why?
| | Cytological Techniques | 1 | 1982 | 27 | 0.010 |
Why?
| | Pulmonary Fibrosis | 1 | 1986 | 399 | 0.010 |
Why?
| | Serum Albumin, Bovine | 1 | 1982 | 63 | 0.010 |
Why?
| | Stimulation, Chemical | 2 | 1978 | 59 | 0.010 |
Why?
| | Imidazoles | 1 | 1983 | 238 | 0.010 |
Why?
| | Leukocyte Adherence Inhibition Test | 1 | 1981 | 1 | 0.010 |
Why?
| | Pulmonary Veins | 1 | 1982 | 99 | 0.010 |
Why?
| | Histoplasmosis | 1 | 1981 | 17 | 0.010 |
Why?
| | Feasibility Studies | 1 | 2005 | 951 | 0.010 |
Why?
| | Vacuoles | 2 | 1978 | 40 | 0.010 |
Why?
| | Bacterial Vaccines | 1 | 1981 | 63 | 0.010 |
Why?
| | Skin Tests | 1 | 1981 | 101 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 1983 | 430 | 0.010 |
Why?
| | Enterococcus faecalis | 2 | 1979 | 26 | 0.010 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1981 | 223 | 0.010 |
Why?
| | Ethane | 1 | 1979 | 2 | 0.010 |
Why?
| | Hexosephosphates | 1 | 1979 | 5 | 0.010 |
Why?
| | Keto Acids | 1 | 1979 | 13 | 0.010 |
Why?
| | Bacteriolysis | 1 | 1979 | 9 | 0.010 |
Why?
| | Ferrous Compounds | 1 | 1979 | 23 | 0.010 |
Why?
| | Anti-Inflammatory Agents | 1 | 1983 | 496 | 0.010 |
Why?
| | Peroxides | 1 | 1979 | 19 | 0.010 |
Why?
| | Chemistry | 1 | 1979 | 45 | 0.010 |
Why?
| | Depression, Chemical | 1 | 1979 | 23 | 0.010 |
Why?
| | Electromagnetic Phenomena | 1 | 1979 | 22 | 0.010 |
Why?
| | Anesthesia, Local | 1 | 1979 | 19 | 0.010 |
Why?
| | Butyrates | 1 | 1979 | 61 | 0.010 |
Why?
| | Aldehydes | 1 | 1979 | 145 | 0.010 |
Why?
| | Blastomyces | 1 | 1978 | 9 | 0.010 |
Why?
| | Immune Sera | 1 | 1978 | 88 | 0.010 |
Why?
| | Heterozygote | 1 | 1979 | 293 | 0.010 |
Why?
| | Immunoglobulins | 1 | 1978 | 171 | 0.010 |
Why?
| | Bronchoscopy | 1 | 1979 | 223 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 1982 | 1481 | 0.010 |
Why?
| | Species Specificity | 1 | 1978 | 584 | 0.010 |
Why?
| | Hypergammaglobulinemia | 1 | 1976 | 9 | 0.010 |
Why?
| | Phenylbutazone | 1 | 1976 | 2 | 0.010 |
Why?
| | Glycolysis | 1 | 1978 | 319 | 0.010 |
Why?
| | Leucine Zippers | 1 | 1996 | 17 | 0.010 |
Why?
| | Oligonucleotide Probes | 1 | 1996 | 51 | 0.010 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 1996 | 37 | 0.010 |
Why?
| | Eczema | 1 | 1976 | 69 | 0.010 |
Why?
| | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 1995 | 5 | 0.010 |
Why?
| | Syndrome | 1 | 1976 | 357 | 0.010 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 1975 | 69 | 0.010 |
Why?
| | Platelet Aggregation | 1 | 1975 | 100 | 0.010 |
Why?
| | Mitochondria, Liver | 1 | 1995 | 73 | 0.010 |
Why?
| | Fungal Proteins | 1 | 1995 | 123 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1975 | 95 | 0.010 |
Why?
| | Protons | 1 | 1995 | 89 | 0.010 |
Why?
| | Genes, Recessive | 1 | 1995 | 78 | 0.010 |
Why?
| | Immunoglobulin E | 1 | 1976 | 342 | 0.010 |
Why?
| | Carbon Radioisotopes | 1 | 1974 | 34 | 0.010 |
Why?
| | Inclusion Bodies | 1 | 1974 | 25 | 0.010 |
Why?
| | Coloring Agents | 1 | 1974 | 87 | 0.010 |
Why?
| | Spleen | 1 | 1996 | 514 | 0.010 |
Why?
| | Staphylococcus | 1 | 1974 | 76 | 0.010 |
Why?
| | Rats, Inbred F344 | 1 | 1994 | 264 | 0.010 |
Why?
| | Vascular Diseases | 1 | 1975 | 243 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 1978 | 871 | 0.010 |
Why?
| | Ibuprofen | 1 | 1992 | 84 | 0.010 |
Why?
| | Solutions | 1 | 1991 | 167 | 0.010 |
Why?
| | Blood | 1 | 1991 | 107 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 1996 | 712 | 0.010 |
Why?
| | Staining and Labeling | 1 | 1991 | 148 | 0.010 |
Why?
| | Nitroglycerin | 1 | 1990 | 17 | 0.010 |
Why?
| | Cold Temperature | 1 | 1991 | 177 | 0.010 |
Why?
| | Insulin | 1 | 1980 | 2406 | 0.010 |
Why?
| | Half-Life | 1 | 1989 | 164 | 0.000 |
Why?
| | Blood Gas Analysis | 1 | 1989 | 74 | 0.000 |
Why?
| | Microspheres | 1 | 1989 | 137 | 0.000 |
Why?
| | DNA-Binding Proteins | 1 | 1996 | 1501 | 0.000 |
Why?
| | Complement C9 | 1 | 1988 | 5 | 0.000 |
Why?
| | Child | 2 | 1979 | 21822 | 0.000 |
Why?
| | Fluoresceins | 1 | 1988 | 47 | 0.000 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 1988 | 35 | 0.000 |
Why?
| | Coronary Vessels | 1 | 1990 | 244 | 0.000 |
Why?
| | Thiocyanates | 1 | 1988 | 31 | 0.000 |
Why?
| | Complement C5 | 1 | 1988 | 81 | 0.000 |
Why?
| | Quinidine | 1 | 1987 | 6 | 0.000 |
Why?
| | Procainamide | 1 | 1987 | 5 | 0.000 |
Why?
| | Phenotype | 1 | 1976 | 3188 | 0.000 |
Why?
| | Virulence | 1 | 1988 | 266 | 0.000 |
Why?
| | Heparin | 1 | 1988 | 260 | 0.000 |
Why?
| | Fluorescent Dyes | 1 | 1988 | 317 | 0.000 |
Why?
| | Anti-Bacterial Agents | 1 | 1976 | 1798 | 0.000 |
Why?
| | Aorta, Thoracic | 1 | 1988 | 267 | 0.000 |
Why?
| | Swine | 1 | 1988 | 773 | 0.000 |
Why?
| | Stroke Volume | 1 | 1988 | 612 | 0.000 |
Why?
| | Pleura | 1 | 1983 | 23 | 0.000 |
Why?
| | Micropore Filters | 1 | 1982 | 6 | 0.000 |
Why?
| | Cytochalasin B | 1 | 1982 | 17 | 0.000 |
Why?
| | Transducers, Pressure | 1 | 1982 | 12 | 0.000 |
Why?
| | Ultrafiltration | 1 | 1982 | 28 | 0.000 |
Why?
| | Polysaccharides, Bacterial | 1 | 1981 | 70 | 0.000 |
Why?
| | Tritium | 1 | 1980 | 76 | 0.000 |
Why?
| | Cytoplasmic Granules | 1 | 1979 | 93 | 0.000 |
Why?
| | Microvilli | 1 | 1978 | 78 | 0.000 |
Why?
| | Myristates | 1 | 1977 | 1 | 0.000 |
Why?
| | Histocompatibility Testing | 1 | 1975 | 126 | 0.000 |
Why?
|
|
Repine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|